Rapid advances with zinc finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs) have transformed our ability to make targeted gene knockouts in zebrafish. Tools and techniques for making ZFN- or TALEN-mediated knockouts are becoming well refined and broadly distributed. Efforts supported by this grant over the previous three years have resulted in the development of publicly available protocols, reagents, and software for engineering ZFNs and TALENs and have generated zinc finger arrays and TALENs for a large set of endogenous zebrafish genes. As a result, today almost any zebrafish investigator can knock out their genes of interest using these resources. Despite the importance of gene knockouts for understanding gene function, null alleles represent only one tool for biological research in zebrafish. To understand gene function completely, methods for controlling gene expression both spatially and temporally would provide powerful tools. Engineered zinc finger and transcription activator-like effector repeat DNA-binding domains have the potential to contribute to all of these areas and to thereby further enhance the utility of the zebrafish as an experimental model. In this renewal application, we propose to continue our highly productive collaborative efforts and to move beyond routine gene knockouts to explore additional novel applications for engineered DNA-binding domains in the zebrafish. During the project period, several novel applications for TALEs will be developed, including the creation of artificial transcription factors, the construction of a set of TALENs tha will enable disruption of all zebrafish microRNAs, and the generation of several different types of conditional alleles.
The specific aims are:
Aim 1 : To develop TALE-based transcription factors for controlling endogenous gene expression in zebrafish.
Aim 2 : To generate a comprehensive set of TALENs targeted to all zebrafish microRNAs (miRNAs).
Aim 3 : To develop novel tools that enable conditional alteration of gene structure and expression. By completing these aims, we will advance the field of genome editing and substantially enhance the utility of the zebrafish as an experimental model. Consistent with our strong and well-established commitment to open-source science, we will continue to make all of the reagents, protocols, and software needed to practice the technologies developed in this proposal publicly available to academic researchers. We believe that the team of researchers for this proposal has a strong track record of productivity working together and of generating tools and reagents that will be broadly useful to the community.

Public Health Relevance

Transcription activator-like effector (TALE) nucleases have transformed our ability to perform reverse genetics studies in zebrafish, an important model organism for studying human development and disease. The experiments of this proposal will advance and expand the toolbox of TALE-based technologies available for studying zebrafish including the development of artificial transcription factors, the generation of a comprehensive set of nucleases for disrupting the expression of zebrafish micro RNAs, and the optimization of several technologies for creating conditional alleles. Successful completion of the aims of this proposal will substantially enhance the utility of the zebrafish as an experimental model and provide important advances in the field of genome editing.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
4R01GM088040-08
Application #
9113587
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Sledjeski, Darren D
Project Start
2009-08-01
Project End
2017-07-31
Budget Start
2016-08-01
Budget End
2017-07-31
Support Year
8
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
Jordi, Josua; Guggiana-Nilo, Drago; Bolton, Andrew D et al. (2018) High-throughput screening for selective appetite modulators: A multibehavioral and translational drug discovery strategy. Sci Adv 4:eaav1966
Rogers, Katherine W; Lord, Nathan D; Gagnon, James A et al. (2017) Nodal patterning without Lefty inhibitory feedback is functional but fragile. Elife 6:
Choi, Tae-Young; Khaliq, Mehwish; Tsurusaki, Shinya et al. (2017) Bone morphogenetic protein signaling governs biliary-driven liver regeneration in zebrafish through tbx2b and id2a. Hepatology 66:1616-1630
Hu, Zhilian; Liu, Yang; Huarng, Michael C et al. (2017) Genome editing of factor X in zebrafish reveals unexpected tolerance of severe defects in the common pathway. Blood 130:666-676
Parant, John M; Yeh, Jing-Ruey Joanna (2016) Approaches to Inactivate Genes in Zebrafish. Adv Exp Med Biol 916:61-86
Kleinstiver, Benjamin P; Pattanayak, Vikram; Prew, Michelle S et al. (2016) High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects. Nature 529:490-5
Rennekamp, Andrew J; Huang, Xi-Ping; Wang, You et al. (2016) ?1 receptor ligands control a switch between passive and active threat responses. Nat Chem Biol 12:552-8
Wan, Xiaoyang; Chen, Zhaohong; Choi, Won-Il et al. (2016) Loss of Epithelial Membrane Protein 2 Aggravates Podocyte Injury via Upregulation of Caveolin-1. J Am Soc Nephrol 27:1066-75
Wyvekens, Nicolas; Tsai, Shengdar Q; Joung, J Keith (2015) Genome Editing in Human Cells Using CRISPR/Cas Nucleases. Curr Protoc Mol Biol 112:31.3.1-18
Gjini, Evisa; Mansour, Marc R; Sander, Jeffry D et al. (2015) A zebrafish model of myelodysplastic syndrome produced through tet2 genomic editing. Mol Cell Biol 35:789-804

Showing the most recent 10 out of 45 publications